Literature DB >> 18198351

Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome.

Yasuhiko Nakagawa1, Ken Kishida, Shinji Kihara, Mina Sonoda, Ayumu Hirata, Atsutaka Yasui, Hitoshi Nishizawa, Tadashi Nakamura, Ryoko Yoshida, Iichiro Shimomura, Tohru Funahashi.   

Abstract

Previous reports demonstrated that adiponectin has antiatherosclerotic properties. Obstructive sleep apnea-hypopnea syndrome (OSAHS) is reported to exacerbate atherosclerotic diseases. We investigated nocturnal alternation of serum adiponectin levels before sleep and after wake-up in OSAHS patients and the effect of sustained hypoxia on adiponectin in vivo and in vitro. We measured serum adiponectin concentrations in 75 OSAHS patients and 18 control subjects before sleep and after wake-up and examined the effect of one-night nasal continuous positive airway pressure (nCPAP) on adiponectin in 24 severe OSAHS patients. We investigated the effects of hypoxia on adiponectin in mice and cultured adipocytes with a sustained hypoxia model. Circulating adiponectin levels before sleep and after wake-up were lower in severe OSAHS patients than in control subjects [before sleep: 5.9 +/- 2.9 vs. 8.8 +/- 5.6 microg/ml (P < 0.05); after wake-up: 5.2 +/- 2.6 vs. 8.5 +/- 5.5 microg/ml (P < 0.01), respectively; means +/- SD]. Serum adiponectin levels diminished significantly during sleep in severe OSAHS patients (P < 0.0001), but one-night nCPAP improved the drop in serum adiponectin levels [-18.4 +/- 13.4% vs. -10.4 +/- 12.4% (P < 0.05)]. In C57BL/6J mice and 3T3-L1 adipocytes, hypoxic exposure decreased adiponectin concentrations by inhibiting adiponectin regulatory mechanisms at secretion and transcriptional levels. The present study demonstrates nocturnal reduction in circulating adiponectin levels in severe OSAHS. Our experimental studies showed that hypoxic stress induced adiponectin dysregulation at transcriptional and posttranscriptional levels. Hypoxic stress is, at least partly, responsible for the reduction of serum adiponectin in severe OSAHS. Nocturnal reduction in adiponectin in severe OSAHS may be an important risk for cardiovascular events or other OSAHS-related diseases during sleep.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18198351     DOI: 10.1152/ajpendo.00709.2007

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  21 in total

1.  Cellular mechanisms in intermittent hypoxia-induced cardiac damage in vivo.

Authors:  Qian Han; Sze C Yeung; Mary S M Ip; Judith C W Mak
Journal:  J Physiol Biochem       Date:  2013-10-12       Impact factor: 4.158

2.  Downregulation of uncoupling protein-1 mRNA expression and hypoadiponectinemia in a mouse model of sleep apnea.

Authors:  Cintia Zappe Fiori; Denis Martinez; Diego Baronio; Darlan Pase da Rosa; Nelson Alexandre Kretzmann; Luiz Felipe Forgiarini; Carolina Caruccio Montanari; Norma Possa Marroni; Alicia Carissimi
Journal:  Sleep Breath       Date:  2013-12-14       Impact factor: 2.816

3.  The impact of obstructive sleep apnea and nasal CPAP on circulating adiponectin levels.

Authors:  Masanori Yoshikawa; Motoo Yamauchi; Yukio Fujita; Noriko Koyama; Atsuhiko Fukuoka; Shinji Tamaki; Yoshifumi Yamamoto; Koichi Tomoda; Hiroshi Kimura
Journal:  Lung       Date:  2014-01-07       Impact factor: 2.584

Review 4.  Interactions between obesity and obstructive sleep apnea: implications for treatment.

Authors:  Abel Romero-Corral; Sean M Caples; Francisco Lopez-Jimenez; Virend K Somers
Journal:  Chest       Date:  2010-03       Impact factor: 9.410

5.  Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea.

Authors:  Jamie C M Lam; Aimin Xu; Sidney Tam; Pek-Ian Khong; Tzy-Jyun Yao; David C L Lam; Agnes Y K Lai; Bing Lam; Karen S L Lam; S M Mary
Journal:  Sleep       Date:  2008-12       Impact factor: 5.849

Review 6.  Obstructive sleep apnea, immuno-inflammation, and atherosclerosis.

Authors:  Claire Arnaud; Maurice Dematteis; Jean-Louis Pepin; Jean-Philippe Baguet; Patrick Lévy
Journal:  Semin Immunopathol       Date:  2009-04-29       Impact factor: 9.623

Review 7.  Molecular signatures of obstructive sleep apnea in adults: a review and perspective.

Authors:  Erna S Arnardottir; Miroslaw Mackiewicz; Thorarinn Gislason; Karen L Teff; Allan I Pack
Journal:  Sleep       Date:  2009-04       Impact factor: 5.849

8.  Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling.

Authors:  Benjamin D Medoff; Yoshihisa Okamoto; Patricio Leyton; Meiqian Weng; Barry P Sandall; Michael J Raher; Shinji Kihara; Kenneth D Bloch; Peter Libby; Andrew D Luster
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-23       Impact factor: 6.914

9.  Obstructive sleep apnea is associated with lower adiponectin and higher cholesterol levels independently of traditional factors and other sleep disorders in middle-aged adults: the ELSA-Brasil cohort.

Authors:  Wagner A Silva; Bianca Almeida-Pititto; Ronaldo B Santos; Aline N Aielo; Soraya Giatti; Barbara K Parise; Silvana P Souza; Sandra F Vivolo; Paulo A Lotufo; Isabela M Bensenor; Luciano F Drager
Journal:  Sleep Breath       Date:  2021-02-15       Impact factor: 2.816

Review 10.  Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis.

Authors:  Lars Hecht; Ralph Möhler; Gabriele Meyer
Journal:  Ger Med Sci       Date:  2011-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.